Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2000-10-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.190353897PMID 11016951PMCID PMC17187
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Oncogene].

  2019cited by this paper
• Cloning and Characterization of Androgen Receptor Coactivator, ARA55, in Human Prostate*

  1999cited by this paper
• Chromatin remodeling and activation of chromosomal DNA replication by an acidic transcriptional activation domain from BRCA1.

  1999cited by this paper
• From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells.

  1999cited by this paper
• Isolation and Characterization of ARA160 as the First Androgen Receptor N-terminal-associated Coactivator in Human Prostate Cells*

  1999cited by this paper
• Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response.

  1999cited by this paper
• Differential induction of androgen receptor transactivation by different androgen receptor coativators in human prostate cancer DU 145 cells

  1999cited by this paper
• Activation of Transcription in Vitro by the BRCA1 Carboxyl-terminal Domain*

  1999cited by this paper
• BRCA1 inhibition of estrogen receptor signaling in transfected cells.

  1999cited by this paper
• Effect of p21waf1/cip1 transgene on radiation induced apoptosis in T cells

  1999cited by this paper
• The Linkage of Kennedy’s Neuron Disease to ARA24, the First Identified Androgen Receptor Polyglutamine Region-associated Coactivator*

  1999cited by this paper
• Androgen regulation of the cyclin-dependent kinase inhibitor p21 gene through an androgen response element in the proximal promoter.

  1999cited by this paper
• Mitogen-Activated Protein Kinase Kinase Kinase 1 Activates Androgen Receptor-Dependent Transcription and Apoptosis in Prostate Cancer

  1999cited by this paper
• Cloning and Characterization of Human Prostate Coactivator ARA54, a Novel Protein That Associates with the Androgen Receptor*

  1999cited by this paper
• Androgens accelerate thymocyte apoptosis.

  1998cited by this paper
• Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest.

  1998cited by this paper
• BRCA1 physically associates with p53 and stimulates its transcriptional activity

  1998cited by this paper
• Induction of growth arrest and cell death by overexpression of the cyclin-Cdk inhibitor p21 in hamster BHK21 cells

  1998cited by this paper
• BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A

  1998cited by this paper
• Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells.

  1998cited by this paper
• Development of human prostate cancer models for chemoprevention and experimental therapeutics studies

  1997cited by this paper
• Association of BRCA1 with Rad51 in mitotic and meiotic cells.

  1997cited by this paper
• Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor.

  1997cited by this paper
• An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter.

  1997cited by this paper
• Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor.

  1997cited by this paper
• Growth retardation and tumour inhibition by BRCA1

  1996cited by this paper
• Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells.

  1996cited by this paper
• Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity.

  1996cited by this paper
• The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse.

  1996cited by this paper
• Androgen receptor: an overview.

  1995cited by this paper
• Rapid detection of BRCA1 mutations by the protein truncation test

  1995cited by this paper
• Radiation-induced cell cycle arrest compromised by p21 deficiency

  1995cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Induction of immature thymocyte proliferation after castration of normal male mice.

  1994cited by this paper
• BRCA1 mutations in primary breast and ovarian carcinomas.

  1994cited by this paper
• Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

  1994cited by this paper
• A point mutation in the second zinc finger of the DNA-binding domain of the androgen receptor gene causes complete androgen insensitivity in two siblings with receptor-positive androgen resistance.

  1993cited by this paper
• Immunohistochemical determination of androgen receptors in relation to oestrogen and progesterone receptors in female breast cancer

  1992cited by this paper
• Characteristics of the biphasic action of androgens and of the potent antiproliferative effects of the new pure antiestrogen EM-139 on cell cycle kinetic parameters in LNCaP human prostatic cancer cells.

  1991cited by this paper
• p53 mutations in human cancers.

  1991cited by this paper
• Steroid hormone receptors compete for factors that mediate their enhancer function.

  1989cited by this paper
• The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor and cell-specific.

  1989cited by this paper
• Molecular cloning of human and rat complementary DNA encoding androgen receptors.

  1988cited by this paper
• The hormone response element of the mouse mammary tumour virus DNA mediates the progestin and androgen induction of transcription in the proviral long terminal repeat region.

  1987cited by this paper

• The interconnection between androgen receptor and DNA damage response pathways in prostate cancer

  2025cites this paper
• Biomarkers of psychological stress are associated with increased susceptibility to the development of breast and prostate cancer in BRCA1/2 mutation carriers

  2025cites this paper
• Intermittent androgen therapy in prostate cancer reveals the pro-apoptotic roles of androgen/androgen receptor: an overview

  2025cites this paper
• SBFI Inhibitors Reprogram Transcriptomic Landscape of Prostate Cancer Cells Leading to Cell Death

  2025cites this paper
• ZFHX3 is integral to androgen/AR signaling involving protein association with AR in prostate cancer cells

  2025cites this paper
• Epigenetics as a determinant of radiation response in cancer.

  2024cites this paper
• The androgen receptor does not directly regulate the transcription of DNA damage response genes

  2023cites this paper
• Potential Therapeutic Targets for Luminal Androgen Receptor Breast Cancer: What We Know so Far

  2023cites this paper
• Structure- and Energy-based Analysis of Small Molecule Ligand Binding to Steroid Nuclear Receptors

  2023cites this paper
• Transcription networks rewire gene repertoire to coordinate cellular reprograming in prostate cancer.

  2023cites this paper
• Androgen/Wnt/β‐catenin signal axis augments cell proliferation of the mouse erectile tissue, corpus cavernosum

  2022cites this paper
• PARP1, BRCA1 and androgen receptor expression in triple-negative breast cancer patients treated with neoadjuvant chemotherapy

  2022cites this paper
• BRCA1 and Metastasis: Outcome of Defective DNA Repair

  2021cites this paper
• Comparative transcriptomic analysis reveals reproductive impairments caused by PCBs and OH-PCBs through the dysregulation of ER and AR signaling.

  2021cites this paper
• AR phosphorylation and CHK2 kinase activity regulates IR-stabilized AR–CHK2 interaction and prostate cancer survival

  2020cites this paper
• Transcription factors in epithelial ovarian cancer: Histotype-specific drivers and novel therapeutic targets.

  2020cites this paper
• Mutational analysis of BRCA1 and BRCA2 genes in women with familial breast cancer from different regions of Colombia

  2019cites this paper
• The Role of Androgen Receptor Signaling in Ovarian Cancer

  2019cites this paper
• Checkpoint kinase 2 regulates prostate cancer cell growth through physical interactions with the androgen receptor

  2019cites this paper
• A model of acquired resistance to the novel AR-NTD inhibitor ralaniten reveals resistance occurs via a selective metabolism pathway

  2018cites this paper
• Chapter 8 Relationship of Breast Cancer with Ovarian Cancer

  2018cites this paper
• An Investigation into the potential anti-cancer activities of an extract from a Himalayan fungus

  2018cites this paper
• Genetic variants as ovarian cancer first-line treatment hallmarks: A systematic review and meta-analysis.

  2017cites this paper
• Baicalein suppresses the androgen receptor (AR)-mediated prostate cancer progression via inhibiting the AR N-C dimerization and AR-coactivators interaction

  2017cites this paper
• BRCA1 and BRCA2 mutations and treatment strategies for breast cancer.

  2017cites this paper
• Profiling of Cross-Functional Peptidases Regulated Circulating Peptides in BRCA1 Mutant Breast Cancer.

  2016cites this paper
• Androgen receptor‐related diseases: what do we know?

  2016cites this paper
• ARTIK-52 induces replication-dependent DNA damage and p53 activation exclusively in cells of prostate and breast cancer origin

  2016cites this paper
• Identification of Potential Anticancer Activities of Novel Ganoderma lucidum Extracts Using Gene Expression and Pathway Network Analysis

  2016cites this paper
• The Correlation Between PARP1 and BRCA1 in AR Positive Triple-negative Breast Cancer

  2016cites this paper
• Nuevas estrategias terapéuticas para el cáncer de próstata

  2015cites this paper
• Relationship of Breast Cancer with Ovarian Cancer

  2015cites this paper
• MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer

  2015cites this paper
• Research resource: EPSLiM: ensemble predictor for short linear motifs in nuclear hormone receptors.

  2014cites this paper
• Award Number: W81XWH-11-1-0097 TITLE: The Role of Skp1-Cul1-F-box Ubiquitin Ligases in Src- Stimulated Estrogen Receptor Proteolysis and Estrogen Receptor Target Gene Expression PRINCIPAL INVESTIGATOR:

  2014cites this paper
• The expression and evaluation of androgen receptor in human renal cell carcinoma.

  2014cites this paper
• Biochemical characterization of the estrogen receptor alpha (ERalpha) coactivator E6-Ap, SKPp2 and FBXL6

  2014cites this paper
• A comparison of the gene expression profiles and pathway network analyses after treatment of Prostate cancer cell lines with different Ganoderma lucidum based extracts.

  2014cites this paper
• BRCA1 and Oxidative Stress

  2014cites this paper
• Dysregulation of cell cycle related genes and microRNAs distinguish the low- from high-risk of prostate cancer

  2014cites this paper
• The convergence of DNA damage checkpoint pathways and androgen receptor signaling in prostate cancer.

  2014cites this paper
• The Wedelolactone Derivative Inhibits Estrogen Receptor-Mediated Breast, Endometrial, and Ovarian Cancer Cells Growth

  2014cites this paper
• Retraction Note: Dysregulation of cell cycle related genes and MicroRNAs distinguish the low- from high-risk of prostate cancer

  2014cites this paper
• The role of BRCA1 and BRCA2 in prostate cancer.

  2013cites this paper
• Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy

  2013cites this paper
• Links between oestrogen receptor activation and proteolysis: relevance to hormone-regulated cancer therapy

  2013cites this paper
• ROLE OF ESTROGEN IN FAMILIAL BREAST CANCER

  2013cites this paper
• Androgen receptor primes prostate cancer cells to apoptosis through down-regulation of basal p21 expression.

  2013cites this paper
• Intrinsic Disorder in PTEN and its Interactome Confers Structural Plasticity and Functional Versatility

  2013cites this paper
• The pharmacogenomics of sex hormone metabolism: breast cancer risk in menopausal hormone therapy.

  2012cites this paper
• Nuevos blancos moleculares en el cáncer de próstata

  2012cites this paper
• Cell - to Species-Level Diversity of Epigenetic Setting for Androgen Receptor Expression in Mammals

  2012cites this paper
• Androgen-modulated p21 and p53 gene expression in human non-transformed epithelial prostatic cells in primary cultures.

  2012cites this paper
• Cryptotanshinone suppresses androgen receptor-mediated growth in androgen dependent and castration resistant prostate cancer cells.

  2012cites this paper
• Expression and function of nuclear receptor co-activator 4: evidence of a potential role independent of co-activator activity

  2012cites this paper
• Overexpression of Androgen Receptor in Prostate Cancer

  2012cites this paper
• The selective inhibitory effect of a synthetic tanshinone derivative on prostate cancer cells

  2012cites this paper
• Molecular biomarkers associated with mutant BRCAl breast cancer patients

  2011cites this paper
• Rol de BRCA1 en la regulación de la transcripción en cáncer de próstata

  2011cites this paper
• Androgen receptor htSNPs in relation to androgen levels and OC use in young women from high-risk breast cancer families.

  2011cites this paper
• Environmental endocrine disruptors: does a sex-related susceptibility exist?

  2011cites this paper
• Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers

  2011cites this paper
• The relevance of BRCA genetics to prostate cancer pathogenesis and treatment.

  2011cites this paper
• BRCA1, BRCA2, AR and IGF-I expression in prostate cancer: correlation between RT-qPCR and immunohistochemical detection.

  2011cites this paper
• Modulation of the tumor cell death pathway by androgen receptor in response to cytotoxic stimuli

  2011cites this paper
• Breast and prostate cancer: more similar than different

  2010cites this paper
• Impact of androgen receptor cytosine-adenine-guanine polymorphisms on clinical outcome in BRCA mutation-associated epithelial ovarian cancers.

  2010cites this paper
• Cancer Biomarker Discovery: The Entropic Hallmark

  2010cites this paper
• Trihydrophobin 1 attenuates androgen signal transduction through promoting androgen receptor degradation

  2010cites this paper
• Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women

  2010cites this paper
• Proteasomal degradation unleashes the pro-death activity of androgen receptor

  2010cites this paper
• Interaction between AR signalling and CRKL bypasses casodex inhibition in prostate cancer.

  2010cites this paper
• Modulation of aryl hydrocarbon receptor activity by four and a half LIM domain 2.

  2009influential citation
• The ordering of expression among a few genes can provide simple cancer biomarkers and signal BRCA1 mutations

  2009cites this paper
• BRCA1 Cross-Talk with Hormone Receptors.

  2009cites this paper
• The effect of cyclin G associated kinase on androgen receptor function and prostate cancer progression

  2009cites this paper
• Human CMTM2/CKLFSF2 enhances the ligand-induced transactivation of the androgen receptor

  2009cites this paper
• Tumor Suppressor BRCA1 Is Expressed in Prostate Cancer and Controls Insulin-like Growth Factor I Receptor (IGF-IR) Gene Transcription in an Androgen Receptor–Dependent Manner

  2009cites this paper
• Androgen Receptor Coregulators and Their Role in Prostate Cancer

  2009cites this paper
• Therapy of Prostate Cancer Using a Human Antibody Targeting the Type 1 Insulin-Like Growth Factor Receptor (IGF-IR)

  2009cites this paper
• A novel splice variant of the nuclear coactivator p120 functions strongly for androgen receptor: characteristic expression in prostate disease.

  2008cites this paper
• Transcription factor and microRNA regulation in androgen-dependent and -independent prostate cancer cells

  2008cites this paper
• Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory.

  2008cites this paper
• A Feedback Loop between the Androgen Receptor and a NEDD4-binding Protein, PMEPA1, in Prostate Cancer Cells*

  2008cites this paper
• Impact of PSA flare-up in patients with hormone-refractory prostate cancer undergoing chemotherapy

  2007cites this paper
• Androgen receptor (AR) coregulators: a diversity of functions converging on and regulating the AR transcriptional complex.

  2007influential citation
• Androgen receptor coregulators and their involvement in the development and progression of prostate cancer

  2007cites this paper
• Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer

  2007cites this paper
• Differentially androgen-modulated genes in ovarian epithelial cells from BRCA mutation carriers and control patients predict ovarian cancer survival and disease progression

  2007cites this paper
• BRCA1 Modulates Xenobiotic Stress-inducible Gene Expression by Interacting with ARNT in Human Breast Cancer Cells*

  2006cites this paper
• BRCA 1 and BRCA 2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells

  2006cites this paper
• The breast cancer susceptibility gene BRCA1 regulates progesterone receptor signaling in mammary epithelial cells.

  2006cites this paper
• UNIVERSIDADE FEDERAL DO RIO GRANDE DO SUL INSTITUTO DE CIÊNCIAS BÁSICAS DA SAÚDE PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIAS BIOLÓGICAS: FISIOLOGIA Modulação androgênica da proliferação celular: expressão do receptor de androgênios, co-reguladores e genes-alvo em células epiteliais prostáticas humanas

  2006cites this paper
• Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells.

  2006cites this paper
• Dehydroepiandrosterone, androgens and the mammary gland

  2006cites this paper
• BRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cells

  2006cites this paper
• Identification of Molecular Receptors for Therapeutic Targeting in Prostate Cancer

  2006cites this paper
• BRCA1 regulation of transcription.

  2006cites this paper
• Expression of steroid hormone receptors in BRCA1-associated ovarian carcinomas.

  2005cites this paper
• Mechanisms of endocrine therapy-responsive and -unresponsive prostate tumours.

  2005cites this paper